SecBot SecBot
8-K ·Filed Oct 16, 2026

EBS

Emergent BioSolutions Inc.
NEUTRAL
Impact 3/10
Horizonmonths Processed11d 20h ago SEC0001367644-26-000098
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

Monitor the FY2026 10-K filing for any material changes in financial reporting or guidance. The CFO transition is orderly with a named internal successor, reducing execution risk. No immediate catalyst.

DirectionNeutral
Confidencehigh
Horizonmonths
Latest settled: T+5d
EBS ▼ -2.35% at T+5d
NEUTRAL call -2.35% · α vs SPY -2.44% · entry $6.38 → $6.23
Next anchor: T+20d in 16d
Entry = T+0 close
Oct 16, 2026
via day close
T+1d
-0.31%
call -0.31% · α -0.74%
$6.36
settled 9d ago
T+5d
-2.35%
call -2.35% · α -2.44%
$6.23
settled 5d ago
T+20d
Pending
in 16d
T+60d
Pending
in 3mo

Price Chart

Loading chart...

Executive Summary

Emergent BioSolutions announced that CFO Richard Lindahl will retire effective December 31, 2026, and will serve as an advisor through March 31, 2027. Frank Vargo, VP Treasurer, has been appointed Interim CFO effective January 1, 2027. The transition is described as part of the company's multi-year transformation plan, with no financial figures or guidance provided.

Key Facts

  • CFO Richard Lindahl steps down as principal financial and accounting officer effective December 31, 2026, retiring March 31, 2027
  • Frank Vargo, VP Treasurer, appointed Interim CFO effective January 1, 2027
  • Lindahl will assist with transition and preparation of FY2026 10-K before retirement
  • Vargo receives interim compensation of an additional $3,850 per pay period on top of current $328,000 base salary
  • Transition described as part of Emergent's multi-year transformation plan

Financial Impact

No financial impact disclosed; CFO transition with named interim replacement and orderly handoff

Risk Factors

  • Interim CFO lacks public company CFO experience — potential for execution missteps during transition
  • Retirement of long-tenured CFO could signal deeper organizational challenges given the company's multi-year transformation plan

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001367644-26-000098
Exhibit: ex991cfoannouncement101626.htm0001367644-26-000098
Document: 0001367644-26-000098-index-headers.html0001367644-26-000098
Document: 0001367644-26-000098-index.html0001367644-26-000098
Document: 0001367644-26-000098.txt0001367644-26-000098
17 reports for EBS
Performance horizon
75% Hit rate @ T+5 3 of 4 directional calls Went positive at some point 3 of 4 best @ T+20▲ +14.89%Apr 29, 2026
Filters
Rows
Reports for EBS, sortable and filterable
TypeNow
Oct 16, 2026
11d ago
8-K
NEUTRAL ★ 3/10
$6.38 $6.23▼ −2.35%▼ −2.44%$6.67 (+4.55%)
Oct 7, 2026
20d ago
144
NEUTRAL ★ 2/10
$6.81 $7.18▲ +5.43%▲ +5.71%$6.67 (−2.06%)
Jun 29, 2026
17w ago
8-K
BULLISH ★ 5/10
$8.46 $8.18▼ −3.31%▼ −4.70%$6.67 (−21.16%)
Jun 4, 2026
20w ago
Press Release
NEUTRAL ★ 2/10
$8.44 $8.39▼ −0.59%▲ +1.96%$6.67 (−20.97%)
Apr 30, 2026
25w ago
Press Release
MIXED ★ 6/10
$8.47 $9.13▲ +7.79%▲ +5.45%$6.67 (−21.25%)
Apr 30, 2026
25w ago
Insider Cluster
NEUTRAL ★ 2/10
$8.23 $9.10▲ +10.57%▲ +8.84%$6.67 (−18.96%)
Apr 29, 2026
25w ago
Press Release
BULLISH ★ 4/10
$7.99 $9.10▲ +13.89%▲ +10.78%$6.67 (−16.52%)
Apr 29, 2026
25w ago
Press Release
NEUTRAL ★ 1/10
$7.99 $9.10▲ +13.89%▲ +10.78%$6.67 (−16.52%)
Apr 28, 2026
26w ago
DEFA14A
NEUTRAL ★ 2/10
$8.23 $8.54▲ +3.77%▲ +2.07%$6.67 (−18.96%)
Apr 28, 2026
26w ago
Press Release
NEUTRAL ★ 4/10
$8.23 $8.54▲ +3.77%▲ +2.07%$6.67 (−18.96%)
Showing 10 of 17

US Market Status

Market Closed · Opens in 5h 12m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 16, 2026